Mo. Code Regs. Ann. tit. 19, § 30-1.002
PURPOSE: The Department of Health and Senior Services has prepared a list of all drugs falling within the purview of controlled substances.
(1) Schedules of Controlled Substances.
(A) Schedule I shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name or brand name designated, listed in this section. Each drug or substance has been assigned the Drug Enforcement Administration (DEA) Controlled Substances Code Number set forth opposite it.
or unless listed in another schedule, any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation:
J. Alpha-methylfentanyl (N-1-(alphamethyl-betaphenyl) ethyl-4-piperidyl) propionanilide; 1-(1-methyl-2- phenylethyl)-4 ((N-propanilido) piperidine) 9814
9603 isomers 9604 NN. 3-Methylthiofentanyl (N- 9605 ((3-methyl-1-(2- thienyl)ethyl-4-piperidinyl)- Nphenylpropanamide) OO. Morpheridine PP. MPPP (1-methyl-4-phenyl- 4-propionoxypiperidine) QQ. MT–45 (1-cyclohexyl- 9626 2. Opium derivatives. Unless specifical- 9627 ly excepted or unless listed in another sched- 9628 ule, any of the following opium derivatives, 9629 its salts, isomers, and salts of isomers when- 9631 ever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation: 19 CSR 30-1
4-(1,2-diphenylethyl) piperazine) (9560) RR. Noracymethadol SS. Norlevorphanol TT. Normethadone UU. Norpipanone VV. N-(2-fluorophenyl)-2- methoxy-N- (1-phenethylpiperidin-4- yl)acetamide, its isomers, esters, ethers, salts and salts of isomers, esters and ethers (Other name: ocfentanil) WW. Para-fluorofentanyl(N- (4-fluorophenyl)-N- (1-(2-phenethyl)-4- piperidinyl) propanamide XX. PEPAP (1-(-2-phenethyl)- 4-phenyl-4- acetoxypiperidine) YY. Phenadoxone ZZ. Phenampromide AAA. Phenomorphan BBB. Phenoperidine CCC. Piritramide DDD. Proheptazine EEE. Properidine FFF. Propiram GGG. Racemoramide HHH. N-(1-phenethylpiperidin- 4-yl)-N- phenyltetrahydrofuran-2- carboxamide, its isomers, esters, ethers, salts and salts of isomers, esters and ethers (Other name: tetrahydrofuranyl fentanyl) III. Thiofentany (N-phenyl-N- (1-(2-thienyl)ethyl-4- piperidinyl)-propanamide JJJ. Tilidine KKK. Trimeperidine
L. Hydromorphinol AND SENIOR SERVICES
Substances scheduled by the United States Drug Enforcement Administration as substances that share a pharmacological profile similar to fentanyl, morphine, and other synthetic opioids, unless specifically excepted or unless listed in another schedule. These substances are:
specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation, which contains any quantity of the following hallucinogenic substances or which contains any of its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation (For purposes of paragraph (1)(A)4. of this rule only, the term isomer includes the optical, position, and geometric isomers.):
Some trade or other names: etryptamine; Monase; alpha-ethyl-1H-indole-3-ethenamine; 3-(2-aminobutyl)indole; alpha-ET; and AET;
Some trade or other names: 4-bromo-2, 5- dimethoxy-a-methylphenethylamine; 4-bromo- 2, 5-DMA;
Some trade or other names: 2,5-dimethoxyamethylphenethylamine; 2,5-DMA;
Some trade or other names: DOET
9302 (2C-E ) 9304 I. 2-(2,5-Dimethoxy-4- 9305 methylphenyl) ethanamine 9306 (2C-D) 9307 J. 2-(2,5-Dimethoxy-4-nitro- 9308 phenyl) ethanamine (2C-N) 9309 K. 2-(2,5-Dimethoxyphenyl) 9312 ethanamine (2C-H) 9313 L. 2-(4-Chloro-2,5- 9314 dimethoxyphenyl) 9315 ethanamine (2C-C)
9822 Some trade or other names: 4-methoxyamethylphenethylamine; paramethoxyamphetamine; PMA;
9547 methylenedioxyamphetamine 7401
Some trade and other names: 4-methyl-2, 5- dimethoxy-a-methylphenethylamine; DOM; and STP;
7249 phenethylamine, N-ethyl MDA,MDE and MDEA)
7391 alpha-methyl-3,4 (methylenedioxy) phenethylamine and N- hydroxy MDA)
7392 trimethoxyamphetamine
7399 Some trade and other names: 3-(b-Dimethylaminoethyl)-5-hydroxyindole; 3-(2-dimethylaminoethyl)-5-indolol; N, N-dimethylserotonin; 5-hydroxy-N, 7348 N-dimethyltryptamine;mappine; AA. Diethyltryptamine Some trade and other names: N, N-Diethyl- 7524 tryptamine; DET; BB. Dimethyltryptamine Some trade or other names: DMT; (other name: 5-MeO- 7508 DIPT)
7521 Some trade and other names: 7-Ethyl- 6,6β,7,8,9,10,12,13-octahydro-2-methoxy-6, 7517 9-methano-5H-pyrido [1’,2’:1,2] azepino [5,4-b] indole; Tabernanthe iboga;
Some trade or other names: marijuana;
Some trade or other names: 3-Hexyl-1- hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-
7518 6H-dibenzo[b,d]pyran; Synhexyl;
Meaning all parts of the plant presently clas-
7532 sified botanically as Lophophora williamsii 7411 Lemaire, whether growing or not; the seeds thereof; any extract from any part of such plant; and every compound, manufacture, salt, derivative, mixture or preparation of such plant, its seeds or extracts;
contained in a plant of the genus Cannabis (cannabis 7370 plant), as well as synthetic
7405 equivalents of the substances contained in the cannabis plant or in the resinous extractives of such plant, and/or synthetic substances, derivatives and their isomers, or both, with similar chemical structure and pharmacological activity to those substances contained in 7404 the plant, such as the following:
nol and their optical isomers;
cannabinol and their optical isomers;
cannabinol and its optical isomers; and
substances is not internationally standard-
7390 ized, compounds of these structures, regardless of numerical designation of atomic posi- 7431 tions are covered.
Some trade or other names: N-ethyl-1- phenylcyclohexylamine, (1-phenylcyclohexyl) ethylamine, N-(1-phenylcyclohexyl)-ethylamine, cyclohexamine, PCE;
Some trade or other names: 1-(1-phenylcyclohexyl)-pyrrolidine PCPy, PHP;
EE. Lysergic acid diethylamide 7315 FF. Marihuana
GG. Mescaline HH. Parahexyl
JJ. N-ethyl-3-piperidyl benzilate KK. N-methyl-3-piperidyl benzilate LL. Psilocybin MM. Psilocyn NN. Tetrahydrocannabinols naturally
OO. Ethylamine analog of phencyclidine
PP. Pyrrolidine analog of phencyclidine
QQ. Thiophene analog of phencyclidine Some trade or other names: 1-(1-(2-thienyl)- cyclohexyl)-piperidine, 2-thienyl analog of phencyclidine, TPCP, TCP; RR. 1-(1-(2-thienyl)cyclohexyl) pyrrolidine 7473 Some other names: TCPy. SS. Salvia divinorum TT. Salvinorin A UU. Synthetic cannabinoids: Unless specifically exempted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances, or which contains their salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:
derived from 3-(1-naphthoyl)indole or 1H- indol-3-yl-(1-naphthyl)methane by substitution at the nitrogen atom of the indole ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2- piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent, whether or not substituted in the naphthyl ring to any extent. Including, but not limited to:
derived from 3-(1-naphthoyl)pyrrole by substitution at the nitrogen atom of the pyrrole ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2- piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the pyrrole ring to any extent, whether or not substituted in the naphthyl ring to any extent;
derived from 1-(1-naphthylmethyl)indene by substitution at the 3-position of the indene ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2- piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indene ring to any extent, whether or not substituted in the naphthyl ring to any extent;
derived from 3-phenylacetylindole by substitution at the nitrogen atom of the indole ring with alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2- piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent, whether or not substituted in the phenyl ring to any extent. Including, but not limited to:
derived from 2-(3-hydroxycyclohexyl)phenol by substitution at the 5-position of the phenolic ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N- methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, whether or not substituted in the cyclohexyl ring to any extent. Including, but not limited to:
2-[(1R,3S)-3- hydroxycyclohexyl]-5-(2-methyloctan-2-yl)phenol), where side chain n=5, and homologues where side chain n-4,6, or 7; 7297, 7298 19 CSR 30-1
(benzoyl)indole structure with substitution at the nitrogen atom of the indole ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2- piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the phenyl ring to any extent. Including, but not limited to:
[(6S,6aR,9R,10aR)-9-hydroxy-6-methyl-3- [ ( 2 R ) - 5 - p h e n y l p e n t a n - 2 - y l ] o x y - 5,6,6a,7,8,9,10,10a-octahydrophenanthridin- 1-yl] acetate (VIII) HU-210, or (6aR,10aR)-9- (hydroxymethyl)-6,6-dimethyl-3-(2-methyl o c t a n - 2 - y l ) - 6 a , 7 , 1 0 , 1 0 a - tetrahydrobenzo[c]chromen-1-ol
Dexanabinol,(6aS,10aS)-9-(hydroxymethyl)- 6,6-dimethyl-3-(2-methyloctan-2-yl)- 6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol
DMHP
excepted or unless listed in another schedule, any material compound, mixture or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:
other names GHB; gamma-hydroxybutyrate; 4-hydroxybutyrate; 4-hydroxybutonic acid; sodium oxybate; sodium oxybutryrate; 2010
excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers, and salts of isomers:
Some trade or other names: aminoxaphen; 2- amino-5-phenyl-2-oxazoline; 4,5-dihydro-5- phenyl-2-oxazolamine;
alphaaminopropiophenone, 2-aminopropiophenone and norephedrone) D. Fenethylline E. 3-Fluoromethcathinone F. 4-Fluoromethcathinone G. Mephedrone, or 4- methylmethcathinone H. Methcathinone
Some trade or other names: 2-(methylamino)- propiophenone; alpha-(methylamino) propiophenone; 2-(methylamino)-1-phenylpropan-1- one; alpha-N-methylaminopropiophenone; monomethylpropion; ephedrone; N-methylcathinone; methylcathinine; AL-464; AL-422; AL-463 and URI 432;
(some other names: N,N-alpha-trimethylbenzeneethanamine; N,N-alphatrimethylphenethylamine)
subject to emergency scheduling under federal law shall include any material, compound, mixture or preparation which contains any quantity of the following substances:
1235 7144 1503 B. [1-(5-fluoro-pentyl)-1H- 1233 indol-3-yl](2,2,3,3- 1238 tetramethylcyclopropyl) methanone, its optical, 1248 positional, and geometric 1237 isomers, salts, and salts of isomers (Other names: 5- fluoro-UR-144, 5-F-UR- 144, XLR11, 1-(5-fluoropentyl)-3-(2,2,3,3- tetramethylcyclopropoyl)indole)
1590 salts of isomer (Other names: APINACA, AKB48) 7048
7535 its optical, positional, and geometric isomers, salts, and salts of isomers (Other names: 7540 25I-NBOMe; 2C-I-NBOMe; 25I; Cimbi-5) 7538
1475 methoxybenzyl)ethanamine, its optical, positional, and geometric isomers, salts, and salts of isomers (Other names: 25C-NBOMe; 2C-C-NBOMe; 25C; Cimbi-82) 7537
7222 dimethoxyphenyl)-N-(2- methoxybenzyl)ethanamine, its optical, positional, and geometric isomers, salts, and 7225 salts of isomers (Other names: 25B-NBOMe; 2C-B-NBOMe; 25B; Cimbi-36) 7536
7012 geometric isomers, salts, and salts of isomers (Other names: 4-MEC; 2-(ethylamino)-1-(4- methylphenyl)propan-1-one) 1249 7035 H. 4-methyl-alphapyrrolidinopropiophenone, its optical, positional, and geometric isomers, salts, and salts of isomers (Other names: 4-MePPP; MePPP; 4-methyl- α-pyrrolidinopropiophenone; 1- (4-methylphenyl)-2-(pyrrolidin- 1-yl)-propan-1-one) 7498
salts of isomers (Other names: α-PVP; α- pyrrolidinovalerophenone; 1-phenyl-2-(pyrrolidin-1- yl)pentan-1-one) 7545 J. Butylone, its optical, positional, and geometric isomers, salts, and salts of isomers (Other names: bk- MBDB; 1-(1,3-benzodioxol-5- yl)-2-(methylamino)butan-1- one) 7541 K. Pentedrone, its optical, positional, and geometric isomers, salts, and salts of isomers (Other names: α- methylaminovalerophenone; 2-(methylamino)-1- phenylpentan-1-one) 1246 L. Pentylone, its optical, positional, and geometric isomers, salts, and salts of isomers (Other names: bk- MBDP; 1-(1,3-benzodioxol- 5-yl)-2-(methylamino)pentan- 1-one) 7542 M. Naphyrone, its optical, positional, and geometric isomers, salts, and salts of isomers (Other names: naphthylpyrovalerone; 1- (naphthalen-2-yl)-2- (pyrrolidin-1-yl)pentan-1- one) 1258 N. alpha-pyrrolidinobutiophenone, its optical, positional, and geometric isomers, salts, and salts of isomers (Other names: α-PBP; 1-phenyl-2-(pyrrolidin- 1-yl)butan-1-one) 7546 O. N-(1-amino-3-methyl-1- oxobutan-2-yl)-1- (cyclohexylmethyl)-1H- indazole-3-carboxamide, its optical, positional, and geometric isomers, salts, and salts of isomers (Other names: AB-CHMINACA) 7031 P. N-(1-amino-3-methyl-1- oxobutan-2-yl)-1-pentyl-1H- indazole-3-carboxamide, its optical, positional, and geometric isomers, salts, and salts of isomers (Other names: AB-PINACA) 7023 Q. [1-(5-fluoropentyl)-1H- indazol-3-yl](naphthalen- 1-yl)methanone, its optical, positional, and geometric isomers, salts, and salts of isomers (Other names: THJ-2201) 7024 R. N-[1-[2-hydroxy-2-(thiophen- 2-yl) ethyl]piperidin-4-yl]- N-phenylpropionamide, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other names: beta-hydroxythiofentanyl) 9836 S. N-(1-phenethylpiperidin-4- yl)-N-phenylacetamide, its optical, positional, and geometric isomers, salts, and salts of isomers (Other names: acetyl fentanyl) 9821 T. N-(1-amino-3,3-dimethyl- 1-oxobutan-2-yl)-1- (cyclohexylmethyl)-1H- indazole-3-carboxamide, its optical, positional, and geometric isomers, salts, and salts of isomers (Other names: MAB-CHMINACA; ADB-CHMINACA) 7032 U. methyl 2-(1-(5- fluoropentyl)-1H-indazole-3- carboxamido)-3,3- dimethylbutanoate, its optical, positional, and geometric isomers, salts and salts of isomers (Other names: 5F–ADB; 5F–MDMB– PINACA) (7034) V. methyl 2-(1-(5- fluoropentyl)-1H-indazole-3- carboxamido)-3- methylbutanoate, its optical, positional, and geometric isomers, salts and salts of isomers (Other names: 5F– AMB) (7033) W. N-(adamantan-1-yl)-1-(5- fluoropentyl)-1H-indazole- 3-carboxamide, its optical, positional, and geometric isomers, salts and salts of isomers (Other names: 5F– APINACA, 5F–AKB48) (7049) X. N-(1-amino-3,3-dimethyl- 1-oxobutan-2-yl)-1-(4- fluorobenzyl)-1H-indazole-3- carboxamide, its optical, positional, and geometric isomers, salts and salts of isomers (Other names: ADB–FUBINACA) (7010) Y. methyl 2-(1- (cyclohexylmethyl)-1H- indole-3-carboxamido)-3,3- dimethylbutanoate, its optical, positional, and geometric isomers, salts and salts of isomers (Other names: MDMB–CHMICA, MMB–CHMINACA) (7042) Z. methyl 2-(1-(4- fluorobenzyl)- 1Hindazole- 3-carboxamido)-3,3- dimethylbutanoate, its optical, positional, and geometric isomers, salts and salts of isomers (Other names: MDMB–FUBINACA) (7020) AA. N-(2-fluorophenyl)-N- (1-phenethylpiperidin- 4-yl)propionamide, its isomers, esters, ethers, salts and salts of isomers, esters and ethers (Other names: orthofluorofentanyl, 2- fluorofentanyl) (9816) BB. 2-methoxy-N-(1- phenethylpiperidin-4-yl)- N-phenylacetamide, its isomers, esters, ethers, salts and salts of isomers, esters and ethers (Other name: methoxyacetyl fentanyl) (9825) CC. methyl 2-(1-(4- fluorobenzyl)-1H-indazole- 3-carboxamido)-3- methylbutanoate, its optical, positional, and geometric isomers, salts and salts of isomers (Other names: FUB–AMB, MMB– FUBINACA, AMB– FUBINACA) (7021) DD. N-(1-phenethylpiperidin-4- yl)-N- phenylcyclopropanecarboxamide, its isomers, esters, ethers, salts and salts of isomers, esters and ethers (Other name: cyclopropyl fentanyl) (9845) EE. N-(1-phenethylpiperidin-4- yl)-N-phenylpentanamide, its isomers, esters, ethers, salts and salts of isomers, esters and ethers (Other name: valeryl fentanyl) (9804) FF. N-(4-fluorophenyl)-N-(1- phenethylpiperidin-4-yl) butyramide, its isomers, esters, ethers, salts and salts of isomers, esters and ethers (Other name: parafluorobutyryl fentanyl) (9823) GG. N-(4-methoxyphenyl)-N- (1-phenethylpiperidin-4- yl)butyramide, its isomers, esters, ethers, salts and salts of isomers, esters and ethers (Other name: paramethoxybutyryl fentanyl) (9837) HH. N-(4-chlorophenyl)-N-(1- phenethylpiperidin- 4-yl)isobutyramide, its 19 CSR 30-1
isomers, esters, ethers, salts and salts of isomers, esters and ethers (Other name: para-chloroisobutyryl fentanyl) (9826) II. N-(1-phenethylpiperidin-4- yl)-N-phenylisobutyramide, its isomers, esters, ethers, salts and salts of isomers, esters and ethers (Other name: isobutyryl fentanyl) (9827) JJ. N-(1-phenethylpiperidin-4- yl)-N- phenylcyclopentanecarboxamide, its isomers, esters, ethers, salts and salts of isomers, esters and ethers (Other name: cyclopentyl fentanyl) (9847) KK. Fentanyl-related substances, their isomers, esters, ethers, salts and salts of isomers, esters and ethers. 9850
means any substance not otherwise listed under another Administration Controlled Substance Code Number, and for which no exemption or approval is in effect under section 505 of the Federal Food, Drug, and Cosmetic Act 21 U.S.C. 355, that is structurally related to fentanyl by one (1) or more of the following modifications:
portion of the phenethyl group by any monocycle, whether or not further substituted in or on the monocycle;
phenethyl group with alkyl, alkenyl, alkoxyl, hydroxyl, halo, haloalkyl, amino or nitro groups;
piperidine ring with alkyl, alkenyl, alkoxyl, ester, ether, hydroxyl, halo, haloalkyl, amino or nitro groups;
ring with any aromatic monocycle whether or not further substituted in or on the aromatic monocycle; and/or
onyl group by another acyl group.
(Other names: 5F-AB-PINACA) (7025) NN. 1-(4-cyanobutyl)-N-(2- phenylpropan-2-yl)-1H- indazole-3-carboxamide, its optical, positional, and geometric isomers, salts and salts of isomers (Other names: 4-CN-CUMYL- BUTINACA; 4-cyano- CUMYL-BUTINACA; 4-CN-CUMYLBINACA; CUMYL-4CN- BINACA; SGT-78) (7089) OO. methyl 2-(1- (cyclohexylmethyl)-1H- indole-3-carboxamido)- 3-methylbutanoate, its optical, positional, and geometric isomers, salts and salts of isomers (Other names: MMB-CHMICA, AMB-CHMICA) (7044) PP. 1-(5-fluoropentyl)-N-(2- phenylpropan-2-yl)-1H- pyrrolo[2,3-b]pyridine-3- carboxamide, its optical, positional, and geometric isomers, salts and salts of isomers (Other names: 5F-CUMYL-P7AICA) (7085) QQ. N-Ethylpentylone, its optical, positional, and geometric isomers, salts and salts of isomers (Other names: ephylone, 1-(1,3- benzodioxol-5-yl)-2- (ethylamino)-pentan-1- one) (7543)
presently classified botanically as catha edulis, whether growing or not; the seeds thereof; any extract from any part of such plant; and every compound, manufacture, salt, derivative, mixture, or preparation of the plant, its seed or extracts. 7032
(B) Schedule II shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section. Each drug or substance has been assigned the Controlled Substances Code Number set forth opposite it.
chemical synthesis. Unless specifically excepted or unless listed in another schedule, Schedule II shall include any of the following substances whether produced directly or indirectly by extraction from substances of vegetable origin or independently by means of chemical synthesis or by a combination of extraction and chemical synthesis:
compound, derivative, or preparation of opium or opiate, excluding apomorphine, thebaine-derived butorphanol, dextrorphan, nalbuphine, nalmefene, naloxegol, naloxone, and naltrexone and their respective salts, but including the following:
preparation thereof which is chemically equivalent or identical with any of the substances referred to in subparagraph (1)(B)1.A. of this rule shall be included in Schedule II, except that these substances shall not include the isoquinoline alkaloids of opium;
compound, derivative, or preparation of coca leaves (including cocaine (9041) and ecgonine (9180) and their salts, isomers, derivatives, and salts of isomers and derivatives), and any salt, compound, derivative, or preparation thereof which is chemically equivalent or identical with any of these substances, except that the substances shall not include:
extraction of coca leaves, which extractions do not contain cocaine or ecgonine; or
crude extract of poppy straw in either liquid, solid, or powder form which contains the phenanthrene alkaloids of the opium poppy)
or unless in another schedule any of the following opiates, including its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation, dextrorphan, and levopropoxyphene excepted:
9620 Some other names: 9639 methadol, levomethadyl acetate, 9640 LAAM
excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system:
excepted or unless listed in another schedule, any material, compound, mixture, or prepa-
9737 ration which contains any quantity of the fol- 9010 lowing substances having a depressant effect 9020 on the central nervous system, including its 9800 salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts (Non-dosage Forms) F. Carfentanil G. Dihydrocodeine H. Diphenoxylate I. Fentanyl J. Isomethadone K. Levo-alphacetylmethadol levo-alphaacetyl-
E. Methylphenidate of isomers is possible within the specific chemical designation:
5. Hallucinogenic substances:
Another name for nabilone: (±)trans-3-(1, 1- dimethylheptyl)-6, 6a,7,8,10,10a-hexahydro- 1-hydroxy-6, 6-dimethyl-9H-dibenzo(b,d) pyran-9-one.
tetrahydrocannabinol] in an oral solution in a drug product approved for marketing by the United States Food and Drug Administration. (7365)
ically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances:
amphetamine and methamphetamine:
Some trade or other names: phenyl-2- propanone; P2P; benzyl methyl ketone; methyl benzyl ketone;
dine (PCP):
C. Immediate precursor to fentanyl:
preparation which contains any quantity of the following alkyl nitrites:
(C) Schedule III shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section. Each drug or substance has been assigned the DEA Controlled Substances Code Number set forth opposite it.
excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers (whether optical, position, or geometric), and salts of such isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:
preparations in dosage unit form containing any stimulant substances listed in Schedule II which compounds, mixtures, or preparations were listed on August 25, 1971, as excepted 2125 compounds under section 308.32 and any 2550 other drug of the quantitive composition 2270 shown in that list for those drugs or which is 7471 the same except that it contains a lesser quan- 2315 tity of controlled substances
7379 C. Chlorphentermine
excepted or unless listed in another schedule, any material compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system:
ration containing:
or any salt thereof and one (1) or more other
to active medicinal ingredients which are not listed in any schedule;
8501 B. Any suppository dosage form containing:
or any salt of any of these drugs and approved by the Food and Drug Administration for marketing only as a suppository;
8603 quantity of a derivative of barbituric acid or any salt thereof
8333 E. Embutramide
gamma hydroxybutyric acid, including its salts, isomers, and salts of isomer, for which an application is approved under section 505 of the Federal Food, Drug, and Cosmetic Act;
Some trade or other names for a tiletaminezolazepam combination product: Telazol. Some trade or other names for tiletamine: 2-
(III) Pentobarbital (ethylamino)-2-(2-thienyl)-cyclohexanone. Some trade or other names for zolazepam: 4- ( 2 - f l u o ro p h e ny l ) - 6 - 8 - d i hyd ro - 1 , 3 , 8 - trimethylpyrazolo-(3,4-e) 7(1H)-one, flupyrazapon.
1405 4. Narcotics drugs. Unless specifically 1228 excepted or unless listed in another schedule, 1645 any material, compound, mixture, or prepa- 1647 ration containing limited quantities of any of 1615 the following narcotic drugs or any salts thereof:
codeine per one hundred milliliters (100 mL) or not more than ninety milligrams (90 mg) per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of opium
2126 codeine per one hundred milliliters (100 mL) 2316 or not more than ninety milligrams (90 mg) 2271 per dosage unit, with one (1) or more active, nonnarcotic ingredients in recognized therapeutic amounts
drocodeine per one hundred milliliters (100 mL) or not more than ninety milligrams (90
2126 mg) per dosage unit, with one (1) or more 2316 active, nonnarcotic ingredients in recognized 2271 therapeutic amounts
milligrams (300 mg) of ethylmorphine per one hundred milliliters (100 mL) or not more than fifteen milligrams (15 mg) per dosage unit, with one (1) or more active,
2100 nonnarcotic ingredients in recognized ther- 2510 apeutic amounts
ligrams (500 mg) of opium per one hundred milliliters (100 mL) or per one hundred grams (100 g) or not more than twenty-five milligrams (25 mg) per dosage unit, with one (1) or more active nonnarcotic ingredients in
2012 recognized therapeutic amounts
mg) of morphine per one hundred milliliters (100 mL) or per one hundred grams (100 g), with one (1) or more active, nonnarcotic ingredients
7285 amounts 7300 5. Any material, compound, mixture, or 7310 preparation containing any of the following 2575 narcotic drugs or their salts, as set forth below:
2261 6. Anabolic steroids. Unless specially 2600 excepted or unless listed in another schedule, 2605 any material, compound, mixture, or prepa- 2610 ration containing any quantity of the following substances, including its salts, isomers, 7295 and salts of isomers whenever the existence of such salts of isomers is possible within the specific chemical designation. DEA has assigned code 4000 for all anabolic steroids. 19 CSR 30-1
(1,4)-diazepin-
F. Not more than fifty milligrams (50
in recognized therapeutic
Anabolic steroids. Any drug or hormonal substance, chemically and pharmacologically related to testosterone (other than estrogens, progestins, corticosteroids, and dehydroepiandrosterone) that promotes muscle growth, except an anabolic steroid which is expressly intended for administration through implants to cattle or other nonhuman species and which has been approved by the Secretary of Health and Human Services for that administration. If any person prescribes, dispenses, or distributes such steroid for human use, such person shall be considered to have prescribed, dispensed, or distributed an anabolic steroid within the meaning of this subdivision. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation containing any quantity of the following substances, including its salts, esters, and ethers:
droxy-5α-androst-1-ene)
droxy-5α-androst-1-ene)
droxy-androst-4-ene)
droxy-androst-5-ene)
1-en-3,17-dione)
3,17-dione)
3,17-dione)
17β-hydroxyandrost-4-en-3-one)
1,4,-diene-3-one)
3,17-dione)
β-hydroxyandrost-4-en-3-one)
yandrost-4-en-3-one)
(4-chloro-17β-hydroxy-17α-methyl-androst- 1,4-dien-3-one)
methyl-5α-androst-2-en-17β-ol) (a.k.a. madol)
drotestosterone) (s) 4-dihydrotestosterone (17β-hydroxy-androstan-3-one)
methyl-5α-androstan-3-one)
hydroxyestr-4-ene)
methyl-11 β,17β-dihydroxyandrost-4-en-3- one)
formyl-17α-methyl-11α,17β-dihydroxyandrost-1,4-dien-3-one)
hydroxyandrostano[2,3-c]-furazan)
one
droxy-androst-4-en-3-one)
(4,17β-dihydroxy-estr-4-en-3-one) AA. Mestanolone (17α-methyl-17β- hydroxy-5α-androstan-3-one) BB. Mesterolone(1α-methyl-17β- hydroxy-[5α]-androstan-3-one)
hydroxyandrost-1,4-dien-3-one)
3β,17β-dihydroxyandrost-5-ene) EE. Methasterone (2α,17α-dimethyl- 5α-androstan-17β-ol-3-one) FF. Methenolone (1-methyl-17β- hydroxy-5α-androst-1-en-3-one) GG. 17α-methyl-3 β,17β-dihydroxy- 5α-androstane HH. 17α-methyl-3α,17β-dihydroxy- 5α-androstane
drost-4-ene JJ. 17α-methyl-4-hydroxynandrolone (17α-methyl-4-hydroxy-17β-hydroxyestr-4- en-3-one) KK. Methyldienolone (17α-methyl- 17β-hydroxyestra-4,9(10)-dien-3-one)
17β-hydroxyestra-4,9,11-trien-3-one)
methyl-17β-hydroxyandrost-4-en-3-one) NN. Mibolerone (7α,17α-dimethyl- 17β-hydroxyestr-4-en-3-one) OO. 17α-methyl-Δ1-dihydrotestosterone (17β-hydroxy-17α-methyl-5α-androst- 1-en-3-one) (a.k.a. 17-α-methyl-1-testosterone) PP. Nandrolone (17β-hydroxyestr-4- ene-3-one) Q Q . 1 9 - n o r - 4 - a n d r o s t e n e d i o l (3β,17β-dihydroxyestr-4-ene) R R . 1 9 - n o r - 4 - a n d r o s t e n e d i o l (3α,17β-dihydroxyestr-4-ene) SS. 19-nor-4,9(10)-androstadienedione (estra-4,9(10)-diene-3,17-dione) TT. 19-nor-5-androstenediol (3β,17β- dihydroxyestr-5-ene) U U . 1 9 - n o r - 5 - a n d r o s t e n e d i o l (3α,17β-dihydroxyestr-5-ene)
4-en-3,17-dione) WW. 19-nor-5-androstenedione (estr- 5-en-3,17-dione)
17β-hydroxygon-4-en-3-one) YY. Norclostebol (4-chloro-17β- hydroxyestr-4-en-3-one) ZZ. Norethandrolone (17α-ethyl-17β- hydroxyestr-4-en-3-one) AAA. Normethandrolone (17α- methyl-17β-hydroxyestr-4-en-3-one) BBB. Oxandrolone (17α-methyl-17β- hydroxy-2-oxa-[5α]-androstan-3-one)
4,17β-dihydroxyandrost-4-en-3-one)
hyd rox y m e t hy l e n e - 1 7 β - hyd rox y - [ 5 α ] - androstan-3-one) EEE. Prostanozol (17β-hydroxy-5α- androstano[3,2-c]pyrazole) FFF. Stanolone (Δ1-dihydrotestosterone (a.k.a. 1-testosterone)(17β-hydroxy- 5α-androst-1-en-3-one)) GGG. Stanozolol (17α-methyl-17β- hydroxy-[5α]-androst-2-eno[3,2-c]-pyrazole) HHH. Stenbolone (17β-hydroxy-2- methyl-[5α]-androst-1-en-3-one)
13,17-secoandrosta-1,4-dien-17-oic acid lactone) JJJ. Testosterone(17β-hydroxyandrost-4-en-3-one); K K K . Te t r a h y d r o g e s t r i n o n e (13β,17α-diethyl-17β-hydroxygon-4,9, 11- trien-3-one)
4,9,11-trien-3-one)
drug or substance described or listed in this subparagraph, if that salt, ester, or isomer promotes muscle growth except an anabolic steroid which is expressly intended for administration through implants to cattle or other nonhuman species and which has been approved by the secretary of Health and Human Services for that administration.
and encapsulated in a soft gelatin capsule in a United States Food and Drug Administration approved drug product 7369 (Some other names for dronabinol: (6aRtrans)- 6a,7,8,10a-tetrahydro-6.6.9- trimethyl-3-pentyl-6H-dibenzo (b,d) pyran-1- ol, or (-) -delta-9-(trans)-tetrahydrocannabinol.)
(D) Schedule IV shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section. Each drug or substance has been assigned the DEA Controlled Substances Code Number set forth opposite it.
excepted or unless listed in another schedule, any material, compound, mixture, or preparation containing limited quantities of any of the following narcotic drugs or any salts thereof:
mg) of difenoxin (DEA Drug Code No. 9168) and not less than twenty-five micrograms (25 mcg) of atropine sulfate per dosage unit
4-dimethylamino-1,2-diphenyl-3-methyl-2- propionoxybutane)
methoxyphenyl)cyclohexanol, its salts, optical and geometric isomers, and salts of these isomers (including tramadol)
cotic active medicinal ingredients. Any compound, mixture, or preparation containing any of the following limited quantities of narcotic drugs or salts thereof, which shall include one (1) or more nonnarcotic active medicinal ingredients in sufficient proportion to confer upon the compound, mixture, or preparation valuable medicinal qualities other than those possessed by the narcotic drug alone:
ligrams (200 mg) of codeine per one hundred milliliters (100 mL) or per one hundred grams (100 g);
milligrams (100 mg) of dihydrocodeine per one hundred milliliters (100 mL) or per one hundred grams (100 g); or
milligrams (100 mg) of ethylmorphine per one hundred milliliters (100 mL) or per one hundred grams (100 g).
excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:
9167 Y. Fospropofol
pound, mixture, or preparation which contains any quantity of the following substances, including its salts, isomers (whether optical, position, or geometric), and salts of such isomers, whenever the existence of such salts, isomers, and salts of isomers is possible:
mixture, or preparation which contains any quantity of the following substances, including its salts, isomers, and salts of isomers, whenever the existence of such salts, isomers, and salts of isomers is possible:
excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers, and salts of isomers:
2759 organometallic complexes 2763 and chelates thereof) 2767 I. Phentermine 2773 6. Other substances. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances, including its salts:
mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system including their salts, isomers, and salts of isomers:
mers, or salts of optical isomers as the only active medicinal ephedrine or its salts, optical isomers, or salts of optical isomers and therapeutically insignificant quantities of another active medicinal ingredient.
(E) Schedule V shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this subsection.
ic active medicinal ingredients. Any compound, mixture, or preparation containing any of the following narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid, in limited quantities as follows, which shall include one (1) or more nonnarcotic active medicinal ingredients in sufficient proportion to confer upon the compound, mixture, or preparation valuable medicinal qualities other than those possessed by the narcotic drug alone:
ligrams (200 mg) of codeine per one hundred milliliters (100 mL) or per one hundred grams (100 g);
ligrams (100 mg) of dihydrocodeine per one hundred milliliters (100 mL) or per one hundred grams (100 g);
ligrams (100 mg) of ethylmorphine per one
1530 hundred milliliters (100 mL) or per one hun- 1640 dred grams (100 g); 19 CSR 30-1
A. Ephedrine or its salts, optical iso-
ingredient or contains
C. Not more than one hundred mil- AND SENIOR SERVICES
milligrams (2.5 mg) of diphenoxylate and not less than twenty-five micrograms (25 mcg) of atropine sulfate per dosage unit;
ligrams (100 mg) of opium per one hundred milliliters (100 mL) or per one hundred grams (100 g); and
ligram (0.5 mg) of difenoxin (DEA Drug Code No. 9168) and not less than twenty-five micrograms (25 mcg) of atropine sulfate per dosage unit.
exempted or excluded or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system including its salts, isomers, and salts of isomers:
tion containing any detectable quantity of pseudoephedrine or its salts or optical isomers, or salts of optical isomers or any compound, mixture, or preparation containing any detectable quantity of ephedrine or its salts or optical isomers, or salts of optical isomers if the drug preparations are starchbased solid dose forms, if such preparations are sold over the counter without a prescription. The following drug preparations containing ephedrine and pseudoephedrine are not scheduled controlled substances:
prescription in order to be dispensed.
excluded or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts:
5. Approved cannabidiol drugs.
formulation that has been approved by the U.S. Food and Drug Administration that contains cannabidiol (2-[1R-3-methyl-6R-(1- methylethenyl)-2-cyclohexen-1-yl]-5-pentyl- 1,3-benzenediol) derived from cannabis and no more than one tenth percent (0.1%) (w/w) residual tetrahydro cannabinols 7367
Bioline Laboratories Aphena Pharma Solutions—New York, LLC Goldline Laboratories Goldline Laboratories Hawthorne Products, Inc. Parke-Davis & Co. Parke-Davis & Co. Parke-Davis & Co. Parke-Davis & Co. Parmed Pharmacy Rondex Labs Smith Kline Consumer Sterling Drug, Inc. Sterling Drug, Inc. Vicks Chemical Co. White Hall Labs
AUTHORITY: sections 195.015 and 195.195, RSMo Supp. 2017.* Material found in this rule previously filed as 19 CSR 30-1.010. Original rule filed April 14, 2000, effective Nov. 30, 2000. Amended: Filed Jan. 31, 2003, effective July 30, 2003. Amended: Filed Sept. 30, 2016, effective May 30, 2017. Emergency amendment filed Oct. 25, 2018, effective Nov. 4, 2018, expired May 2, 2019. Amended: Filed Oct. 25, 2018, effective April 30, 2019. *Original authority: 195.015, RSMo 1971, amended 1989, 2014, 2017 and 195.195, RSMo 1957, amended 1971, 1989, 1993, 2014, 2017.